T-cell subset composition and functionality in patients with Waldenström’s macroglobulinemia-Reference-Cited by-同舟云学术

T-cell subset composition and functionality in patients with Waldenström’s macroglobulinemia

Published:2022-02-01 Issue:6 Volume:63 Page:1469-1473
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Amaador Karima¹,Martens Anne¹²,de Boer Renate²,Rietveld Joanne²,Heemskerk Mirjam³,Rutten Caroline E.¹,Eldering Eric²⁴,Kersten Marie-José¹⁴^ORCID,Kater Arnon P.¹⁴,Vos Josephine¹⁴,Tonino Sanne¹⁴

Affiliation:

1. Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands

2. Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Amsterdam, The Netherlands

3. Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands

4. Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2022.2030478

Reference17 articles.

1. CXCR4 in Waldenström’s Macroglobulinema: chances and challenges

3. Gene-expression profiling of Waldenström macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma

4. Definition and characterization of the systemic T-cell dysregulation in untreated indolent B-cell lymphoma and very early CLL

5. Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Broadening the horizon: potential applications of CAR-T cells beyond current indications;Frontiers in Immunology;2023-11-27

2. First-Line Treatment of Waldenström’s Macroglobulinaemia: Considerations Based on the Dutch National Guideline;Hemato;2022-10-26

3. Treatment of relapsed and refractory Waldenstrom Macroglobulinemia;Leukemia & Lymphoma;2022-10-25